Zaki MH - Search Results

1

Synergistic enhancement of cell-mediated immunity by interleukin-12 plus interleukin-2: basis for therapy of cutaneous T cell lymphoma.

Zaki MH, Wysocka M, Everetts SE, Wang KS, French LE, Ritz J, Rook AH. Zaki MH, et al. J Invest Dermatol. 2002 Feb;118(2):366-71. doi: 10.1046/j.1523-1747.2002.01646.x. J Invest Dermatol. 2002. PMID: 11841558 Free article.

2

New biologic agents for the treatment of cutaneous T-cell lymphoma.

Vittorio CC, Junkins-Hopkins JM, McGinnis KS, Shapiro M, Wysocka M, Zaki MH, French LE, Rook AH. Vittorio CC, et al. Among authors: zaki mh. Recent Results Cancer Res. 2002;160:321-8. doi: 10.1007/978-3-642-59410-6_37. Recent Results Cancer Res. 2002. PMID: 12079230 Review.

3

Sézary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines.

Wysocka M, Zaki MH, French LE, Chehimi J, Shapiro M, Everetts SE, McGinnis KS, Montaner L, Rook AH. Wysocka M, et al. Among authors: zaki mh. Blood. 2002 Nov 1;100(9):3287-94. doi: 10.1182/blood-2002-01-0231. Blood. 2002. PMID: 12384429 Free article.

4

Biological effects of bexarotene in cutaneous T-cell lymphoma.

Budgin JB, Richardson SK, Newton SB, Wysocka M, Zaki MH, Benoit B, Rook AH. Budgin JB, et al. Among authors: zaki mh. Arch Dermatol. 2005 Mar;141(3):315-21. doi: 10.1001/archderm.141.3.315. Arch Dermatol. 2005. PMID: 15781672

5

Dysregulation of lymphocyte interleukin-12 receptor expression in Sézary syndrome.

Zaki MH, Shane RB, Geng Y, Showe LC, Everetts SE, Presky DH, Wysocka M, Moore JS, Rook AH. Zaki MH, et al. J Invest Dermatol. 2001 Jul;117(1):119-27. doi: 10.1046/j.0022-202x.2001.01354.x. J Invest Dermatol. 2001. PMID: 11442758 Free article.

6

The role for interleukin-12 therapy of cutaneous T cell lymphoma.

Rook AH, Zaki MH, Wysocka M, Wood GS, Duvic M, Showe LC, Foss F, Shapiro M, Kuzel TM, Olsen EA, Vonderheid EC, Laliberte R, Sherman ML. Rook AH, et al. Among authors: zaki mh. Ann N Y Acad Sci. 2001 Sep;941:177-84. doi: 10.1111/j.1749-6632.2001.tb03721.x. Ann N Y Acad Sci. 2001. PMID: 11594571 Clinical Trial.

7

Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10.

Geng Y, Shane RB, Berencsi K, Gonczol E, Zaki MH, Margolis DJ, Trinchieri G, Rook AH. Geng Y, et al. Among authors: zaki mh. J Immunol. 2000 May 15;164(10):5522-9. doi: 10.4049/jimmunol.164.10.5522. J Immunol. 2000. PMID: 10799921

8

Disruption of the IFN-gamma cytokine network in chronic lymphocytic leukemia contributes to resistance of leukemic B cells to apoptosis.

Zaki M, Douglas R, Patten N, Bachinsky M, Lamb R, Nowell P, Moore J. Zaki M, et al. Leuk Res. 2000 Jul;24(7):611-21. doi: 10.1016/s0145-2126(00)00022-9. Leuk Res. 2000. PMID: 10867137 Free article.

9

Clinical cytokine network cytometry.

Moore JS, Zaki MH. Moore JS, et al. Among authors: zaki mh. Clin Lab Med. 2001 Dec;21(4):795-809. Clin Lab Med. 2001. PMID: 11770288 Review.

10

CNTO 328, a monoclonal antibody to IL-6, inhibits human tumor-induced cachexia in nude mice.

Zaki MH, Nemeth JA, Trikha M. Zaki MH, et al. Int J Cancer. 2004 Sep 10;111(4):592-5. doi: 10.1002/ijc.20270. Int J Cancer. 2004. PMID: 15239138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters